Leerink Partnrs Issues Negative Forecast for ARDT Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Equities research analysts at Leerink Partnrs cut their Q1 2025 earnings estimates for shares of Ardent Health Partners in a note issued to investors on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $0.20 per share for the quarter, down from their previous forecast of $0.33. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q2 2025 earnings at $0.61 EPS.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion.

A number of other equities analysts have also recently issued reports on ARDT. Morgan Stanley reduced their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, January 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Royal Bank of Canada dropped their price objective on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 4th. Finally, Stephens reiterated an “overweight” rating and set a $22.00 target price on shares of Ardent Health Partners in a report on Tuesday, April 1st. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $21.18.

Ardent Health Partners Price Performance

NYSE:ARDT opened at $12.22 on Friday. The stock’s fifty day simple moving average is $14.25 and its 200-day simple moving average is $16.06. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a 12-month low of $12.13 and a 12-month high of $20.72.

Hedge Funds Weigh In On Ardent Health Partners

Hedge funds have recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. bought a new stake in Ardent Health Partners during the fourth quarter worth about $27,000. US Bancorp DE acquired a new position in shares of Ardent Health Partners during the 4th quarter worth approximately $31,000. R Squared Ltd bought a new stake in shares of Ardent Health Partners during the 4th quarter worth approximately $37,000. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners in the 3rd quarter valued at approximately $42,000. Finally, New York State Common Retirement Fund acquired a new position in Ardent Health Partners during the fourth quarter worth $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.